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Natural antimicrobial agents, particularly essential oils present an excellent alternative
to current antibiotics due to their potent and broad-spectrum antimicrobial potential,
unique mechanisms of action and low tendency to induce resistance. However their
potential as a viable therapeutic alternative is greatly compromised due to their
hydrophobic and volatile nature. The objective of the current research was to explore
the anti-pathogenic potential of essential oils in a bio-based nano-carrier system.
Six different essential oils were tested on multidrug-resistant bacterial pathogens.
However, cardamom oil was selected for nano-encapsulation because of most potent
anti-microbial activity. Cardamom oil loaded chitosan nano-particles were prepared
by ionic gelation method with an encapsulation efficiency of more than 90% and
size was estimated to be 50–100 nm. The Zeta potential was more than +50 mV
that indicate a stable nano-dispersion. Cytotoxicity analysis indicated non haemolytic
and non-cytotoxic behaviour on human corneal epithelial cells and HepG2 cell lines.
Cardamom oil loaded chitosan nano-particles were found to exhibit excellent anti-
microbial potential against extended spectrum β lactamase producing Escherichia coli
and methicillin resistant Staphylococcus aureus. Our results suggested safety and
efficacy of cardamom oil loaded chitosan nano-particles for treating multidrug-resistant
pathogens hence offer an effective alternative to current antibiotic therapy.
Keywords: natural active agents, cardamom essential-oil, multidrug resistance, chitosan nanocapsules, MRSA,
cytotoxicity
INTRODUCTION
Community associated or hospital-acquired infectious diseases resulting from multidrug-resistant
pathogens are considered leading cause of morbidity and mortality, especially in developing
countries (Laxminarayan et al., 2013). The injudicious use of antibiotics is the single most
important factor leading to antibiotic resistance around the world (Centres for Disease Control,
and Prevention [CDC], 2013). Center for Disease Control (CDC) has endorsed the need for
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development of new antibiotics. However, the development of
new antibiotics is expensive and time consuming. Meanwhile
the genetic plasticity in pathogens results in development of
resistance at a rapid rate (Centres for Disease Control, and
Prevention [CDC], 2013; Lee et al., 2013). To tackle this issue
there is a dire need to search for safe alternative therapies (Jamil
et al., 2015).
Natural products have garnered the attention of many
researchers in recent years as complementary and alternative
antimicrobial agents (Jeon et al., 2011; Calo et al., 2015).
Essential oils (EOs) are natural plant products comprised of
complex mixtures of biologically active substances and offer
potential novel template molecules and bioactive compounds
(Maida et al., 2014). EOs are composed of volatile secondary
metabolites having antibacterial, antifungal, anti-inflammatory,
antioxidant, anticancer, and antiviral activities (Espina et al.,
2011; Hossain et al., 2014; Aumeeruddy-Elalfi et al., 2015;
Sharifi-Rad et al., 2015). The efficiency of the EOs depends
on its chemical composition, genotypes, environmental, and
agronomic conditions (Mohamed et al., 2014). Recent studies
have highlighted the antimicrobial potential of EOs with few
reports against multidrug-resistant bacteria (Kon and Rai, 2012;
Coelho and Pereira, 2013; Nazzaro et al., 2013). Furthermore,
the use of EOs as food preservatives has also been described
by many to control food pathogens (Djenane et al., 2013;
Perricone et al., 2015). In the pharmaceutical field, EOs have
been included in the composition of many dosage forms
to impart flavor and natural preservation (Mohamed et al.,
2014).
Despite the excellent antimicrobial activity of EOs against
pathogenic microorganisms, their utilization is very limited
due to low water solubility and less stability to environmental
factors including heat, moisture, and oxygen. To improve
water dispersion and protect EOs from degradation, nano-sized
formulations emerge as a viable solution (São Pedro et al., 2009;
Donsì et al., 2011; Acevedo-Fani et al., 2015; El Asbahani et al.,
2015). Moreover, nano-encapsulation improves the antibacterial
activity of several antibiotics (El Asbahani et al., 2015; Jamil et al.,
2016).
Chitosan (CS) has proven to be a cost effective carrier
for many pharmaceutical agents (Piras et al., 2015). Major
characteristics that make it an ideal carrier system are its
biodegradability, biocompatibility, availability, safety, cationic
charge and innate antimicrobial potential. The present work has
been done to investigate the microscopic, physico-chemical and
cytotoxic attributes of cardamom EOs functionalized engineered
CS nanoparticles (CSNPs). Not yet reported cardamom EO
potential at nano-scale to treat multidrug-resistant pathogens
was also explored which may provide a bio-based alternative to
overcome existing therapeutic challenges posed by multidrug-
resistant pathogens.
MATERIALS AND METHODS
Cardamom, Lemon, rose, peppermint, eucalyptus, and orange
EOs were purchased from local market. CS medium molecular
weight was purchased from Sigma–Aldrich (Product number
448877, 75–85% deacetylation, 200–800 cP viscosity of 1% w/v
in 1% v/v acetic acid). Pentasodium tripolyphospate (TPP) and
glacial acetic acid were also procured from Sigma–Aldrich. All
antibiotic disks were obtained from Oxoid.
Microbial Culture Collection
All microbial cultures were collected from Al-Sayed Hospital,
Rawalpindi and they were identified and characterized by
standard biochemical tests and by using Analytical Profile Index
(API) kit. These pathogens were preserved in glycerol broth and
kept at−20◦C.
Both Gram positive [Methicillin-resistant S. aureus (MRSA)]
and Gram negative (E. coli) microbes were employed in the
study. Resistance pattern of selected microbes was performed by
Kirby Bauer disk diffusion method. Following antibiotic disks
were used, Ceftazidime (CAZ 30 µg), Cefazolin (KZ 30 µg),
Cefotaxime (CTX 30 µg), Imipenem (IPM), Cefepime (FEP),
Cefoxitin (FOX 30 µg) Ceftriaxone (CRO 30 µg), Aztreonam
(ATM 30 µg), Ampicillin (AMP 25 µg), Vancomycin (VA 30 µg),
Meropenem (MEM 10 µg), and Augmentin (AMC 30 µg) and
zones of inhibitions were compared with CLSI guidelines (CLSI,
2016; EUCAST, 2016).
EO Screening for Anti-bacterial Activity
Screening of EOs to compare their antimicrobial potential was
performed by agar well diffusion method. Briefly, inoculum
was prepared in normal saline from pure culture and turbidity
was compared to that of 0.5% McFarland solution. With the
help of sterilized cotton bud microbial lawn was prepared on
agar surface in all directions by rotating the plate at 90◦angle.
Wells were prepared on inoculated agar surface with the help
of sterilized borer. Different EOs were poured in each well
(50 µL). Plates were then incubated at 37◦C for overnight
incubation. Next day zones of inhibitions were measured. EO
with the best antimicrobial activity was chosen for nano-
encapsulation.
Determination of Minimum Inhibitory
Concentration (MIC)
Minimum inhibitory concentration of cardamom oil was carried
out on both solid (by agar well diffusion method) and liquid
media (broth dilution method). Cardamom oil was first serially
diluted in different ratios with distilled water. Each dilution was
poured in wells prepared on inoculated agar Petri plate. It was
then incubated at 37◦C. Next day highest dilution displaying zone
of inhibition was marked and recorded as MIC.
Broth microdilution method was performed according to
the protocol mentioned by Duarte et al. (2015) with some
modifications. Briefly, 9 mL nutrient broth was sterilized in test
tubes and each test tube was inoculated with 10µL inoculum after
matching turbidity with turbidity standard. Then 1 mL of each of
cardamom oil dilution was added in each inoculated test tube. All
test tubes were then incubated at 37◦C for 18 h. After incubation
highest dilution giving visibly clear broth was marked as MIC.
Both positive and negative controls were also added. Negative
Frontiers in Microbiology | www.frontiersin.org 2 October 2016 | Volume 7 | Article 1580
fmicb-07-01580 October 3, 2016 Time: 16:56 # 3
Jamil et al. EOs Based Nanocomposites: Alternative Therapeutics
control had only the nutrient broth and positive control had the
inoculated broth (Duarte et al., 2015).
Preparation of CSNPs
Chitosan nano-particles were prepared using ionic gelation
process as described earlier (Piras et al., 2015; Jamil et al.,
2016). For this purpose, two solutions were prepared. CS and
tripolyphosphate (TPP) solution.
Chitosan solution was prepared by adding 0.3 g CS in 1%
acetic acid solution (100 mL). It was subjected to continuous
stirring until a clear solution was obtained. Whereas TPP solution
was prepared by adding 0.1 g TPP in water (10 mL). TPP solution
(4 mL) was added drop wise to the CS solution (100 mL) with
continuous stirring. Nano-particles (NPs) formed spontaneously
upon addition of TPP aqueous solution. The mixture was stirred
at room temperature for 2 more hours. The NPs were then
subjected to extensive ultrasonication (Cole-parmer ultrasonic
processor) at 35 Hz for at least 30 min on ice bath to avoid
temperature raise. It was subjected to centrifugation at 14000 g
for 30 min at 4◦C (Eppendorf 5804R Benchtop Centrifuge).
For the preparation of cardamom oil loaded CSNPs, 4 mL of
the cardamom oil was taken and mixed with 4 mL of TPP
solution.
Characterization of NPs
Scanning Electron Microscopy (SEM)
Scanning electron microscopy is a method for high-resolution
imaging of surfaces. SEM analysis was done by using Jeol JSM
6490A analytical scanning electron microscope. Sample was
prepared on a glass slide (1× 1 cm) after washing it with ethanol.
A tiny drop of nanodispersion was spreaded evenly over glass
slide and allowed to air dry. In order to make it conductive, gold
coating with Jeol Quick Auto Coater was performed (JFC-1500).
The NPs were then subjected to SEM analysis under ambient
conditions.
3D Structure Evaluation: Atomic Force Microscopy
(AFM)
While SEM) provides 2 dimensional (2D) images of sample,
AFM studies were performed to get the 3 dimensional (3D)
images. AFM Imaging was carried out by using Scanning Probe
Microscope (Model: SPM 9600 Company: Shimadzu) in tap
mode. Samples were prepared in a similar fashion as for SEM
analysis without any further sample treatment.
Interaction and Bonding Analysis of EOs with NPs
Fourier transform infrared spectroscopy (FTIR) studies were
conducted to get information about the interaction pattern
and release of EOs from nano-scaffolds. For an effective drug
delivery system, it is necessary that the active agent must
be released slowly from the carrier moiety. If the interaction
between carrier and drug is strong, drug will not be released.
FTIR was conducted using Bruker-Tensor 27 Fourier transform
spectrometer (Bruker Daltonik GmbH, Bremen, Germany) in
order to observe the existing and newly formed functional groups
between CS and EOs.
Determination of Zeta Potential
Nanoparticles have the natural tendency to form agglomerates
due to van der Walls attractive forces dominating over repulsive
forces between the particles. Zeta potential is the charge on
diffused aqueous layer formed on NP surface as it is kept in
water. Zeta potential was measured through Malvern zeta sizer
(NanoZS) at room temperature.
Determination of Encapsulation Efficiency
The quantity of EO loading in CSNPs was determined by the
method of Abreu with slight modifications (Abreu et al., 2012).
λmax was calculated for various dilutions of cardamom oil by
using nanophotometer (Implen). At 295 nm (λmax), a clear peak
was observed. Based upon readings of various dilutions, standard
curve was constituted. The trend line was obtained by linear
regression with standard equation (Y = 0.7979X − 1.0021)
and R2 value (0.9848). Drug loaded CSNPs were isolated from
the free drug by centrifugation (16,000 g, 25 min, Eppendorf
5415D, Eppendorf, Germany) and supernatant was quantified
by spectrophotometer at λmax (295 nm). The encapsulation
efficiency (EE) of cardamom EO loaded CSNPs was determined
using the following equation:
Encapsulation efficiency = Encapsulated EO/Total EO × 100
Cytotoxicity Studies of NPs
These tests were done to assess the safety of NPs for in vivo
application (Dehn et al., 2004).
In vitro Hemolysis Analysis
Whole blood was collected in acid-citrate-dextrose (ACD)
Vacutainer. Blood sample was mixed with the NPs suspension
in 1% concentration and incubated at 37◦C for 45 min.
Unexposed samples (negative control), distilled H2O (vehicle
control) and 1% SDS (positive control) were included as
experimental controls. Samples were centrifuged at 14000 rpm
for 5 min and absorbance of the supernatant was measured
at 540 nm using Nanodrop2000 (Dobrovolskaia et al., 2008).
Percentage hemolysis was calculated relative to the untreated
control.
Cytotoxicity Screening on Human
Hepatocellular Carcinoma Cell Line
Human hepatocellular carcinoma cell line HepG2 (ATCC
HB-8065TM) was sub-cultured and maintained in DMEM
supplemented with fetal bovine serum (FBS) 10%, Na-pyruvate
(1 mM), L-glutamine (2 mM), penicillin (100 U/mL) and
streptomycin (100 µg/mL) at 37◦C, and 5% CO2 under
humidified conditions.
Potential cytotoxic effects of nanoparticles were determined
via sulforhodamine B (SRB) assay as described previously
(Skehan et al., 1990). In short, HepG2 cultures (10000 cells/well)
were exposed to the cardamom oil loaded nanoparticles and
incubated for 24 h at 37◦C and 5% CO2. As negative control,
untreated cultures were also included in each experiment. At
the end of the incubation time, cultures were fixed by adding
50% pre-chilled trichloroacetic acid (TCA) and further incubated
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at 4◦C for 1 hour. The samples were thoroghly washed with
deionized water and air dried. Cells were then stained with SRB
solution (0.4%) for 30 min and washed with acetic acid (1%)
and dried overnight. Dried samples were photographed with
a Olympus IMT-2 inverted microscope equipped with digital
camera.
Cytotoxicity Screening on Human
Corneal Epithelial Cells
Human corneal epithelial (HCEC; RIKEN Bio Resource Center,
Japan) cells were maintained in a mixture (ratio 1:1) of
Ham’s F12 and Dulbecco’s Modified Eagle Medium (DMEM),
supplemented with FBS (10%), L-glutamine (2 mM), Na-
pyruvate (1 mM), penicillin–streptomycin (100 U/ml) at 37◦C
in a 5% CO2 incubator, under humidified environment. Cell
harvesting was done by trypsin/EDTA (0.5 mM) at room
temperature.
To analyze the toxic effects of the nanoparticles, pre-seeded
HCEC cells (>90% viability; 15,000 cells/well) were exposed to
the nanoparticles at 100 µg/ml for 24 h. Unexposed samples
and non-cellular background (culture media only and media
+ NPs only) were included as experimental controls. Cell
viability was assessed using MTT [3-(4,5-Dimethylthiazol-2-
yl)-2,5-Diphenyltetrazolium Bromide] assay as described earlier
(Mosmann, 1983). Briefly, at the end of incubation period, MTT
reagent (0.5 mg/ml) was added and further incubated for 3 h
at 37◦C. The resulting Formazan crystals were dissolved by the
addition of an equal amount of acidified 10% SDS for overnight.
Absorbance was taken at 565 nm by using microplate reader
(AMP PLATOS R-496) and percentage viabilities of the samples
were determined relative to unexposed sample using following
formula:
Viability (%) = [Abs (565) test sample − Abs (565)media
+ NPs only/Abs (565) unexposed
− Abs (565)media] × 100
where Abs (565) test sample and Abs (565) unexposed represent
the optical density (OD) values of exposed and unexposed
samples, respectively. Abs (565) media + NPs only and Abs
(565) media are representatives of background OD measured for
‘media+ NPs only’ and ‘media only’ samples.
Kinetics of Bacterial Inactivation
Antibacterial activity of antibiotic loaded CSNPs was determined
through standard micro-dilution broth assays. Bacterial turbidity
of E. coli and Methicillin-resistant S. aureus inoculated in nutrient
broth was compared to Mc-farland standards after 24 h of
incubation. Ten microliters of the bacterial suspensions were
added to 9 mL of sterilized broth and identical concentrations
of antibiotic and nano-antibiotic formulations were added in
inoculated broth and all test tubes were incubated in shaker
incubator at 37◦C. After 24 h OD values were measured at
595 nm on ELISA Multiplate reader. Experiment was run
in triplicate and both positive and negative controls were
added.
TABLE 1 | Resistance spectra of selected microbes by disk diffusion
method.
Antibiotic disk Zone of Inhibition (mm)
E. coli MRSA
Ceftazidime (CAZ) 30 µg 20a –
Cefazolin (KZ) 30 µg –a –
Cefoxitin (FOX) 30 µg –a –
Imipenem (IPM) 10 µg 32b –
Cefepime (FEP) 30 µg 17c –
Ceftriaxone (CRO) 30 µg 11a –
Aztreonam (ATM) 30 µg 15c –
Ampicillin (AMP) 25 µg – –
Vancomycin (VA) 30 µg – 20
Meropenem (MEM) 10 µg 32b –
Augmentin (AMC) 30 µg –a 20
Agar Petri plates were inoculated with test organisms and antibiotic disks were
applied over it. After 24 h incubation zone of inhibitions were measured in mm.
aESBL Phenomenon was exhibited between these antibiotic discs so their exact
zones cannot be interpreted.
Whereas MRSA, methicillin-resistant Staphylococcus aureus.
bSusceptible.
c-Resisatant.
–No zone of inhibition.
TABLE 2 | Screening of essential oils (EOs) by agar well diffusion assay.
Volatile oil E. coli (mm) MRSA (mm)
Cardamom 22 39
Rose oil 22 22
Peppermint oil No No
Lemon oil No 18
Orange oil 14 12
Eucalyptus oil 14 15
Agar plates were seeded with microbial inoculum and 50 µL EOs were poured in
each well. Following 24 h incubation zones of inhibitions were measured.
MRSA, Methicillin-resistant S. aureus.
RESULTS
Resistance Spectra of Selected
Pathogens
In the present investigation, E. coli and S. aureus were used to
determine antimicrobial efficacy of our Cardamom oil-loaded
CSNPs. Both microbes were subjected to disk diffusion method
to determine their resistance pattern (Table 1). S. aureus was
resistant to FOX disk that is why it was called MRSA. While the
E. coli was found to be extended spectrum β lactamase (ESBL)
producer, as zone augmentation was observed between AMC
disk and other cephalosporin disks. Both of the pathogens were
observed to be multidrug resistant.
EO Screening and MIC Determination
Essential oils were subjected to agar well diffusion assay to
determine efficacy of selected EOs against multidrug-resistant
pathogens (Table 2). It was observed that cardamom oil was
most active against both MRSA and ESBL producing E. coli so
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it was selected for encapsulation in NPs. Cardamom oil emulsion
was prepared in various dilutions with distilled water. MIC was
calculated to be 25 % (Percent v/v) for E. coli and (10 %) (Percent
v/v) for MRSA.
Characterization of NPs
Chitosan NPs were prepared by ionic gelation method and then
subjected to various characterization techniques to ascertain their
size and shape. SEM (Figure 1) and AFM (Figure 2) analysis
depicted CSNPs size to be 50–100 nm with quite uniformity in
both size and shape. More than 90% encapsulation efficiency of
cardamom oil loaded CSNPs was observed.
Interaction Studies of Cardamom Oil
with CSNPs
Fourier transform infrared spectroscopy spectra of CS powder
shows characteristic peaks at 3433 cm−1 (OH and NH2
stretching), 2920 cm−1 (CH stretching), 1647 cm−1 (amide I),
1088 cm−1 (C–O–C stretching; Figure 3A). Pure cardamom
FIGURE 1 | Scanning Electron Microscope (SEM) micrographs.
Morphological evaluation of chitosan nano-particles (CSNPs) by scanning
electron microscope (SEM) micrographs at 55000×.
FIGURE 2 | Atomic Force Microscope (AFM) image. AFM micrograph of
CSNPs was taken at room temperature. Maximum height of 70 nm was
observed.
oil spectra displays sharp characteristic peaks at 3331 cm−1
(OH stretching), 2971 cm−1 (OH stretching), 1710 cm−1
(C = O stretch representing aldehyde or ketones), 1458 cm−1
(CH2 bending), 1377 cm−1 (CH bending), and 1333 cm−1
(C–N stretching; Figure 3B). For empty CSNPs (Figure 3C),
the amide I (NH2 bending) peak shifted from 1647 to
1641 cm−1, and new peaks appeared at 1280 cm−1 (C–
N stretch) implying the complex formation via electrostatic
interaction between NH3+ groups of CS and phosphoric
groups of TPP within the nanoparticles. All the above
characteristic peaks also appear in the spectra of cardamom
oil loaded CSNPs at almost the same wave number indicating
no modification or interaction between the EO and CSNPs
(Figure 3D).
Stability of Cardamom Oil with CSNPs
Zeta potential studies predicted long term stability as the zeta
potential values were more than 50 mV in both empty and
cardamom oil-loaded CSNPs (Figure 4).
Cytotoxicity Studies
Potential cytotoxic effects of the cardamom oil loaded CSNPs was
performed via hemolysis and potential to induce morphological
alterations in mammalian cells. Both empty and EOs-loaded
CSNPs did not display any hemolytic effect (Figure 5).
Furthermore, no necrotic damage to monolayer cell lines or any
change in cell morphology was observed (Figures 6 and 7).
Antimicrobial Activity of Cardamom
Oil-Loaded CSNPs
According to the results of the current study, cardamom oil
alone failed to inhibit both pathogens because cardamom oil
was incorporated below MIC (Figure 8). Both empty CSNPs and
EOs-loaded CSNPs effectively controlled the growth of pathogens
for first 48 h. However, after 48 h growth appeared with empty
CSNPs whereas the EOs-loaded CSNPs maintained their anti-
microbial potential till 7 days (Figure 8).
DISCUSSION
Essential oils of plant origin are used both domestically and
industrially. According to an estimate more than 3000 EOs have
been produced by different plants. However, almost 300 are
important from the commercial point of view. EO market all
over the world is estimated to be 700 million US$ (Raut and
Karuppayil, 2014).
In the present study we encapsulated EOs in CSNPs and then
their antimicrobial potential on multidrug-resistant S. aureus
and E. coli was determined. The S. aureus was confirmed to
be MRSA because it was exhibiting resistance against cefoxitin
disk. The proportion of S. aureus isolates that are resistant to
methicillin is increasing rapidly. Previously, it was considered
as nosocomial pathogen. However, infections caused by oxacillin
(methicillin)-resistant S. aureus (MRSA) are a problem not only
in health care institutions but also in community as well (Klevens
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FIGURE 3 | Fourier transform infrared spectroscopic (FTIR) spectra of (A) CS raw material, (B) cardamom oil raw material, (C) blank CSNPs, and (D)
cardamom oil-loaded CSNPs. From these images it can be observed that the FTIR image of CSNPs and EOs loaded CSNPs are almost superimposable,
indicating no chemical reaction between CS and EOs. The entrapment of EOs is mere physical.
FIGURE 4 | Zeta Potential of (A) blank CSNPs and (B) cardamom oil-loaded CSNPs. Zeta potential was measured through Malvern Instrument. A positive
zeta potential of more than 50 mV was observed for both blank and EOs loaded CSNPs.
et al., 2006). E. coli used in the study was ESBL positive. The
prevalence of (ESBL) positive E. coli is also reported to be very
high. According to a study it was estimated that almost 70–
90% of E. coli population is ESBL positive (Kumarasamy et al.,
2010). ESBL positive pathogens are considered to be resistant to
whole cephalosporin range and the only safe treatment for curing
ESBL positive pathogens is carbapenem and now the pathogens
have developed resistance against carbapenem as well. So the
clinicians are left with no safe antibiotics and there is a dire
need to search for new antibiotics against which microbes cannot
develop resistance rapidly.
Elettaria cardamomum (cardamom, family; Scitaminaceae)
is a perennial herb, indigenous to India, Pakistan, Burma, and
Sri Lanka (Khan et al., 2011). In addition to its wide use for
culinary purpose, cardamom has folkloric repute as carminative,
stomachic, diuretic, antibacterial, antiviral, antifungal and is
considered useful in treatment of constipation, colic, diarrhoea,
dyspepsia, vomiting, headache, epilepsy, and cardiovascular
diseases (Gilani et al., 2008). Besides cardamom oil, the
antimicrobial properties of several other EOs against a number
of pathogenic microorganisms involved in foodborne illness have
been demonstrated in previous investigations (Roby et al., 2013;
Zhang et al., 2016).
Previous studies have reported MIC of cardamom EO at 0.4%
against S. aureus ATCC 6538 and 0.8% against E. coli ATCC 8739
(Gochev et al., 2012). However, in the present study we tested
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FIGURE 5 | Hemolysis analysis. Evaluation of % hemolysis induced by
chitosan NP and cardamom oil-loaded CSNPs. It can be observed that both
empty and EOs-loaded CSNPs are not causing hemolysis.
FIGURE 6 | Cytotoxicity analysis on Human corneal epithelial cells.
Growth and survival of Human corneal epithelial cells was assessed by MTT
[3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide] assay.
the EOs against multi drug resistant pathogens that is why higher
MIC values were achieved as compare to previous reports.
Numerous studies have reported an enhancement of the
physical and antimicrobial properties of EOs-loaded nano-
emulsions as compared to their conventional emulsions
(Buranasuksombat et al., 2011; Liang et al., 2012; Salvia-Trujillo
et al., 2014; Severino et al., 2015). The encapsulation of eugenol
FIGURE 7 | Cytotoxicity analysis on HepG2 cancerous cell line (A)
untreated HepG2 cells and (B) blank CSNPs (C) essential oil-loaded
CSNPs. Cytotoxicity testing was done to check the safety of NPs on human
cell. It can be observed that both the blank and EOs loaded chitosan NPs
were not causing any cell damage.
and carvacrol into nanometric surfactant micelles also resulted
in enhanced antimicrobial activity. However, not yet reported
previously, cardamom oil was encapsulated in CSNPs to protect
it and to achieve antimicrobial activity at low dose below MIC
value against MDR pathogens.
Hosseini et al. (2013) reported oregano loaded CSNPs by
incorporating Tween, however, in the present study, cardamom
oil-loaded CSNPs were prepared directly by ionic gelation
method after mixing EO with TPP. It was observed after SEM
(Figure 1) and AFM (Figure 2) analysis that NPs were in the
range of 50–100 nm and they were uniformly distributed. CS
is a very popular material as nano-carrier and has been widely
studied by numerous authors. However, varying sizes in the range
of 40–500 nm have been reported previously (Abreu et al., 2012;
Hosseini et al., 2013).
While studying the interaction of cardamom oil with CS
scaffolds, the materials were subjected to FTIR analysis. CS
powder shows characteristic peaks that were in accordance to
previously reported spectra (Khan et al., 2002; Vitali et al.,
2006). The results of FTIR indicated that cardamom oil might be
encapsulated into the CSNPs. Evidence of EOs and CS interaction
was in good agreement with previous literature (Abreu et al.,
2012). The CS and EOs-loaded CSNPs were subjected to stability
testing by means of zeta potential analysis. Zeta potential studies
FIGURE 8 | Growth kinetics of (A) Escherichia coli (B) Methicillin-resistant Staphylococcus aureus. It can be observed that the cardamom oil-loaded
CSNPs have completely eradicated both pathogens whereas, bare CSNPs initially controlled the pathogens for 2 days after that a rapid growth was observed.
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predicted long term stability as the zeta potential values
were more than + 60 mV in both empty and cardamom
oil loaded CSNPs (Figure 4). Results of this study were in
good accordance to the previous data (Calvo et al., 1997;
Raja et al., 2013; Chang et al., 2015). A charge of more
than + 30 mV is consider as an indicator of stability as the
mutual repulsive forces would be more as compare to van
der walls attractive forces between the NPs. In addition to
stability the positive charge on both empty and loaded CSNPs
indicated good interaction with pathogens as well. Bacterial
cell wall carries negative charge and our developed NPs are
carrying positive charge so there is a prediction of very strong
interaction.
Our results of cytotoxicity were also found to be in accordance
with the results of De Campos, where it was observed that both
HCEC and HepG2 cell lines after CSNPs treatment yielded 100%
cells viability (De Campos et al., 2004). Hemolysis or destruction
of red blood cells is a very significant aspect to be considered for
in vivo applications of all pharmaceutical agents as it can lead
to anemia, jaundice and other pathological conditions. CSNPs
were found to be absolutely non-hemolytic. Our results were
found to be in good accordance to the findings of Zhou et al.
(2015).
The antimicrobial potential of medicinal plants is well
documented. Donsì investigated the nano-encapsulation of
EO and has reported enhanced antimicrobial effect against
multiple pathogens causing food spoilage (Donsì et al., 2011;
Aumeeruddy-Elalfi et al., 2015). Moreover, Liang also reported
enhanced and prolonged antimicrobial activity of EOs after
nano-encapsulation (Liang et al., 2012). However, this is the
first report on nano-encapsulation of cardamom oil in CSNPs.
According to our findings cardamom oil loaded CSNPs were
highly effective in combating both ESBL-producing E. coli and
MRSA. Whereas, cardamom oil alone failed to eradicate them.
However, the CSNP inhibited the growth of pathogens till first
48 h after that there was a rapid increase in optical density of both
pathogens.
The positive charge due to the presence of –NH+3 have been
mentioned as important factors that influence the antibacterial
activities of CS (Chang et al., 2015). The strong adhesive
properties of CS with bacteria are due to these opposite charges.
However, to maintain the antimicrobial potential of CS, it must
be incorporated with some antimicrobial agents and naturally
occurring antimicrobials are the best choice for this purpose.
It serves dual purpose, protecting the EOs from degradation
for prolonged antimicrobial efficacy and sustaining the innate
inhibitory effect of CS to inhibit resistant superbugs.
CONCLUSION
Cardamom EO-loaded CS nano-capsules were observed to be
highly effective in controlling multi drug resistant E. coli and
MRSA in vitro without showing any signs of toxicity to human
cells.
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